We also discovered UNC93B1 expression levels positively correlated with CD14 (r = 0.672, p < 0.001, Figure 5C), a surface antigen that is preferentially expressed on monocytes and a molecule associated to shorter overall survival and lower complete remission rate in AML (Solary et al., 1992; Bradstock et al., 1994). The gene discussed is UNC93B1; the disease is acute myeloid leukemia.